N. Inoue

Spleen‐derived dendritic cells engineered to enhance interleukin‐12 production elicit therapeutic antitumor immune responses

M. Mizumoto, S. Arii, A. Mori, 2000, International journal of cancer.

Dendritic Cells Coinjected with Tumor Cells Treated with an Anticancer Drug to Induce Tumor Rejection

M. Imamura, T. Kan, K. Furumoto, 2003, Surgery Today.

Induction of human leukocyte antigen (HLA)‐A2‐restricted and MAGE‐3‐gene‐derived peptide‐specific cytolytic T lymphocytes using cultured dendritic cells from an HLA‐A2 esophageal cancer patient

M. Kaneko, M. Imamura, A. Otaka, 1999, Journal of surgical oncology.

Production of specific antibody and T helper 1-dominant cytokine elicited by dendritic cells genetically modified with an adenovirus vector.

S. Arii, M. Imamura, S. Yamasaki, 1999, Immunology letters.

Prospective Antitumor Effects of the Combination of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) and Cisplatin Against Esophageal Squamous Cell Carcinoma

T. Kan, Y. Shimada, T. Sugie, 2006, Surgery Today.

Interleukin-12-gene transduction makes DCs from tumor-bearing mice an effective inducer of tumor-specific immunity in a peritoneal dissemination model.

S. Arii, A. Mori, M. Imamura, 2002, Immunology letters.

Activation of human natural killer cells by the protein-bound polysaccharide PSK independently of interferon and interleukin 2.

A. Uchida, T. Mori, K. Sugie, 1992, Immunology letters.

Lysis of Fresh Human Tumor Cells by Autologous Peripheral Blood Lymphocytes and Tumor‐infiltrating Lymphocytes Activated hy PSK

A. Uchida, H. Kanzaki, K. Sugie, 1991, Japanese journal of cancer research : Gann.